NCT01778140

Brief Summary

The investigators hypothesize that a Clinical Decision Support System (CDSS) designed with "Patient-Specific" reminders yields superior performance than that with "Non-patient-specific" reminders in preventing contrast-induced nephropathy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2012

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

December 26, 2012

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 29, 2013

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
Last Updated

February 6, 2013

Status Verified

February 1, 2013

Enrollment Period

1.5 years

First QC Date

December 26, 2012

Last Update Submit

February 5, 2013

Conditions

Keywords

Clinical Decision Support SystemsContrast-induced nephropathy

Outcome Measures

Primary Outcomes (1)

  • The percentage of contrast-enhanced imaging(CEI) orders with high CIN risk

    The number of CEI ordered for patients at high CIN risk, divided by the total number of CEI orders. \[CEI\]: contrast-enhanced image studies,such as CT or IVU. \[CIN\]: contrast-induced nephropathy

    Physicains who participated in this trial will be followed for an expected average of 12 months

Secondary Outcomes (1)

  • The order elimination rate of high CIN risk orders attributed to the computerized reminder

    Physicains who participated in this trial will be followed for an expected average of 12 months

Study Arms (3)

Patient-specific reminder

EXPERIMENTAL

Intervention: Patient-specific computerized reminder. The physicians assigned to this arm will use the patient-specific CDSS on CPOE. The patient-specific reminder is designed as a real-time CDSS implemented on CPOE to monitor physician's contrast-enhanced image study orders. Computerized pop-up reminders provide the patient-specific CIN risk profile and optimal decision options which are generated when patients with high risk or with unknown risk of CIN are encountered.

Other: Patient-specific computerized reminder

Non-patient-specific reminder

ACTIVE COMPARATOR

Intervention: Non-patient-specific Computerized reminder. The physicians assigned to this arm will use the Non-patient-specific reminders through CPOE. Non-patient-specific reminders always pops up to remind physicians to check their patient's CIN risk no matter what CIN risk is.

Other: Non-patient-specific computerized reminder

Control Arm

NO INTERVENTION

The physicians assigned to this arm will not use and any computerized reminder.

Interventions

The intervention targets are physicians,not patients. This CDSS alerts physicians only when the patient with high risk of contrast-induced-nephropathy(CIN) is encountered. On the contrast, the CDSS will not alert when the patient without CIN risk is encountered.

Also known as: Patient-specific CDSS
Patient-specific reminder

The non-patient-specific computerized reminder always pops up to remind physicians to check their patient's CIN risk no matter what CIN risk is.

Also known as: Non-patient-specific CDSS
Non-patient-specific reminder

Eligibility Criteria

Age25 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Our intervention targets are physicians but not patients. All physicians working in the hospital may join this trial.

You may not qualify if:

  • The physician who never orders a CT scan or IVU study will be excluded
  • The physician who never operates the CPOE by himself or herself will be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei medical university hospital

Taipei, 110, Taiwan

Location

Study Officials

  • Yu-Chuan Li

    Taipei Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 26, 2012

First Posted

January 29, 2013

Study Start

January 1, 2012

Primary Completion

July 1, 2013

Study Completion

August 1, 2013

Last Updated

February 6, 2013

Record last verified: 2013-02

Locations